Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 2
1994 1
2005 1
2008 1
2012 1
2013 1
2014 2
2015 3
2016 4
2018 2
2019 3
2020 1
2021 2
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
ALSUntangled 59: Tamoxifen.
Bedlack R, Kihuwa-Mani S, Barkhaus PE, Bereman M, Caress JB, Crayle J, Pattee GL, Heiman Patterson T, Wicks P, Zach N, Carter GT, Salmon K. Bedlack R, et al. Among authors: zach n. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):595-598. doi: 10.1080/21678421.2021.1876731. Epub 2021 Jan 21. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 33474997
PRO-ACTive sharing of clinical data.
Zach N, Leitner ML. Zach N, et al. Nat Biotechnol. 2022 Jul;40(7):999-1000. doi: 10.1038/s41587-022-01395-y. Nat Biotechnol. 2022. PMID: 35778617 No abstract available.
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
Zach N, Ennist DL, Taylor AA, Alon H, Sherman A, Kueffner R, Walker J, Sinani E, Katsovskiy I, Cudkowicz M, Leitner ML. Zach N, et al. Neurotherapeutics. 2015 Apr;12(2):417-23. doi: 10.1007/s13311-015-0336-z. Neurotherapeutics. 2015. PMID: 25613183 Free PMC article. Review.
Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach.
Kueffner R, Zach N, Bronfeld M, Norel R, Atassi N, Balagurusamy V, Di Camillo B, Chio A, Cudkowicz M, Dillenberger D, Garcia-Garcia J, Hardiman O, Hoff B, Knight J, Leitner ML, Li G, Mangravite L, Norman T, Wang L; ALS Stratification Consortium; Xiao J, Fang WC, Peng J, Yang C, Chang HJ, Stolovitzky G. Kueffner R, et al. Among authors: zach n. Sci Rep. 2019 Jan 24;9(1):690. doi: 10.1038/s41598-018-36873-4. Sci Rep. 2019. PMID: 30679616 Free PMC article.
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.
Stephenson D, Alexander R, Aggarwal V, Badawy R, Bain L, Bhatnagar R, Bloem BR, Boroojerdi B, Burton J, Cedarbaum JM, Cosman J, Dexter DT, Dockendorf M, Dorsey ER, Dowling AV, Evers LJW, Fisher K, Frasier M, Garcia-Gancedo L, Goldsack JC, Hill D, Hitchcock J, Hu MT, Lawton MP, Lee SJ, Lindemann M, Marek K, Mehrotra N, Meinders MJ, Minchik M, Oliva L, Romero K, Roussos G, Rubens R, Sadar S, Scheeren J, Sengoku E, Simuni T, Stebbins G, Taylor KI, Yang B, Zach N. Stephenson D, et al. Among authors: zach n. Digit Biomark. 2020 Nov 26;4(Suppl 1):28-49. doi: 10.1159/000512500. eCollection 2020 Winter. Digit Biomark. 2020. PMID: 33442579 Free PMC article. Review.
Predicting disease progression in amyotrophic lateral sclerosis.
Taylor AA, Fournier C, Polak M, Wang L, Zach N, Keymer M, Glass JD, Ennist DL; Pooled Resource Open‐Access ALS Clinical Trials Consortium. Taylor AA, et al. Among authors: zach n. Ann Clin Transl Neurol. 2016 Sep 7;3(11):866-875. doi: 10.1002/acn3.348. eCollection 2016 Nov. Ann Clin Transl Neurol. 2016. PMID: 27844032 Free PMC article.
Design and analysis of a clinical trial using previous trials as historical control.
Schoenfeld DA, Finkelstein DM, Macklin E, Zach N, Ennist DL, Taylor AA, Atassi N; Pooled Resource Open-Access ALS Clinical Trials Consortium. Schoenfeld DA, et al. Among authors: zach n. Clin Trials. 2019 Oct;16(5):531-538. doi: 10.1177/1740774519858914. Epub 2019 Jul 1. Clin Trials. 2019. PMID: 31256630 Free PMC article.
25 results